logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
B

Baek‐Yeol Ryoo

Asan Medical Center

64H指数
499论文数
1.7W被引数
收录论文 152
发表时间
logo
Real-world outcomes of lenvatinib versus sorafenib as the second-line therapy after atezolizumab plus bevacizumab in patients with hepatocellular carcinoma: a large-scale multicenter study in Korea仑伐替尼与索拉非尼作为阿替利珠单抗联合贝伐珠单抗后肝癌患者的二线治疗真实世界疗效：一项韩国大规模多中心研究
errHepatology International
IF6.1
err2026-09-11
err0
errOAAI
errMin Ji Lee; Subin Lim; Jae Yong Shim; Mi Na Kim; DongKyu Kim; Kyu‑pyo Kim; Kang Mo Kim; Baek‑Yeol Ryoo; Won‑Mook Choi; Hyun‑Jeong Kim; Seung‑Hoon Lee; Gaeun Kang; Mira Kang; Won Chul Cha; Jung Yong Hong; Woo Kyoung Jeong; Sung Kyung Ju; Jung‑Hyun Won; Doik Lee; Jiyoon Ahn; Do Young Kim
err分享
err收藏
Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter StudyLenvatinib和Sorafenib作为肝细胞癌一线治疗的真实世界比较：一项多中心研究
errJournal of Hepatocellular Carcinoma
IF3.4
err2025-11-25
err0
errOAAI
errMira Kang; Won Chul Cha; Dong Hyun Sinn; Woo Kyoung Jeong; Do Young Kim; Min Ji Lee; Subin Lim; DongKyu Kim; Kyu-Pyo Kim; Baek-Yeol Ryoo; Won-Mook Choi; Kang Mo Kim; Ki-Hun Kim; Doik Lee; Eui Jun Choi; Choungwon Jung; Joohyun Kim; Jung Yong Hong
err分享
err收藏
Multicenter phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab多中心II期临床试验，评估仑伐替尼在经一线阿替利珠单抗联合贝伐珠单抗治疗后进展的晚期肝细胞癌患者中的应用。
errJournal of Hepatology
IF33
err2025-09-04
err0
errOAAI
errHyung-Don Kim; Sun Jin Sym; Hong Jae Chon; Moonho Kim; Jung Hun Kang; Baek-Yeol Ryoo; Choong-kun Lee; Joohyun Hong; Hyewon Ryu; Woo Kyun Bae; Hyeyeong Kim; Hyunho Kim; Jin Won Kim; Tae-Yong Kim; Changhoon Yoo
err分享
err收藏
Risk of Variceal Bleeding in Patients Receiving Atezolizumab-Bevacizumab Treatment for Hepatocellular Carcinoma接受阿特珠单抗-贝伐单抗治疗的肝细胞癌患者发生静脉曲张破裂出血的风险
errALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
err2025-01-28
err0
PREAI
errPark, Kanghee; Lee, Hye Won; Kim, Euichang; Choi, Won-Mook; Lee, Danbi; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Han Chu; Yoo, Changhoon; Ryoo, Baek-Yeol; Han, Seungbong; Choi, Jonggi
err分享
err收藏
Multicenter Phase 2 Trial of Second-Line Regorafenib in Patients with Unresectable Hepatocellular Carcinoma after Progression on Atezolizumab plus Bevacizumab阿特珠单抗联合贝伐单抗治疗进展后不可切除肝细胞癌患者二线Regorafenib的多中心2期试验
errLIVER CANCER
IF9.1
err2025-01-21
err0
errOAAI
errCheon, Jaekyung; Ryoo, Baek-Yeol; Kim, Hyung-Don; Ryu, Min-Hee; Kim, Kyu-Pyo; Kang, Beodeul; Finn, Richard S.; Chan, Stephen Lam
err分享
err收藏
Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-analysis Based on Individual Patient-Level Data of Randomized Trials二线以氟嘧啶为基础的化疗在晚期胆道癌中的应用：一项基于随机试验个体患者数据的Meta分析
errCANCER RESEARCH AND TREATMENT
IF3.8
err2024-10-17
err0
errOAAI
errHyung, Jaewon; Kang, Minsu; Kim, Ilhwan; Kim, Kyu-pyo; Ryoo, Baek-Yeol; Cheon, Jaekyung; Ryu, Hyewon; Lee, Ji Sung; Kim, Ji-Won; Choi, In Sil; Park, Jin Hyun; Abou-Alfa, Ghassan K.; Kim, Jin Won; Yoo, Changhoon
err分享
err收藏
Impact of Etiology on Efficacy Outcomes with Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Retrospective Analysis in Asia-Pacific病因学对晚期肝细胞癌患者阿特珠单抗联合贝伐单抗疗效结局的影响: 亚太地区的跨国回顾性分析
errTARGETED ONCOLOGY
IF4
err2024-10-03
err0
PREAI
errKim, Sejin; Lee, Suat Ying; Cheon, Jaekyung; Kim, Hyung-Don; Park, Young Gyu; Lee, Joycelyn Jie Xin; Ryu, Min-Hee; Ryoo, Baek-Yeol; Tai, David; Yoo, Changhoon
err分享
err收藏
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract Cancer
errCLINICAL CANCER RESEARCH
IF10.2
err2024-08-16
err1
PREAI
errBang, Yeong Hak; Lee, Choong-kun; Bang, Kyunghye; Kim, Hyung-Don; Kim, Kyu-pyo; Jeong, Jae Ho; Park, Inkeun; Ryoo, Baek-Yeol; Lee, Dong Ki; Choi, Hye Jin; Chung, Taek; Jeon, Seung Hyuck; Shin, Eui-Cheol; Oum, Chiyoon; Kim, Seulki; Lim, Yoojoo; Park, Gahee; Ahn, Chang Ho; Lee, Taebum; Finn, Richard S.; Ock, Chan-Young; Shin, Jinho; Yoo, Changhoon
err分享
err收藏
Efficacy and safety of bintrafusp alfa in 2 phase I expansion cohorts with advanced HCC
errHEPATOLOGY
IF15.8
err2024-08-13
err0
PREAI
errLim, Ho Yeong; Heo, Jeong; Peguero, Julio A.; Ryoo, Baek-Yeol; Decaens, Thomas; Barlesi, Fabrice; Moehler, Markus H.; Jehl, Genevieve; Eggleton, S. Peter; Bajars, Marcis; Gulley, James L.
err分享
err收藏
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment
errJOURNAL OF HEPATOLOGY
IF33
err2024-08-01
err6
PREAI
errChan, Stephen L.; Ryoo, Baek-Yeol; Mo, Frankie; Chan, Landon L.; Cheon, Jaekyung; Li, Leung; Wong, Kwan H.; Yim, Nicole; Kim, Hyeyeong; Yoo, Changhoon
err分享
err收藏
Metabolic tumor burden as a prognostic indicator after neoadjuvant chemotherapy in pancreatic cancer
errINTERNATIONAL JOURNAL OF SURGERY
IF10.1
err2024-07-01
err1
errOAAI
errLee, Woohyung; Oh, Minyoung; Kim, Jae Seung; Sung, Minkyu; Hong, Kwangpyo; Kwak, Bong Jun; Park, Yejong; Jun, Eunsung; Song, Ki Byung; Hwang, Dae Wook; Lee, Jae Hoon; Yoo, Changhoon; Kim, Kyu-pyo; Park, Inkeun; Jeong, Jae Ho; Chang, Heung-Moon; Ryoo, Baek-Yeol; Lee, Jung Bok; Kim, Song Cheol
err分享
err收藏
Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database Study
errLIVER CANCER
IF9.1
err2024-06-14
err0
errOAAI
errKim, Kyu-Pyo; Kim, Kang Mo; Ryoo, Baek-Yeol; Choi, Won-Mook; Cha, Won Chul; Kang, Mira; Sinn, Dong Hyun; Goh, Myung Ji; Kim, Do Young; Lee, Min Ji; Lim, Subin; Kim, Dongkyu; Baek, Kyoungdae; Kim, Joohyun; Choi, Eui Jun; Lee, Doik; Kim, Jung-Ae; Kim, Ki-Hun
err分享
err收藏
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study卡博替尼联合阿特珠单抗与索拉非尼治疗晚期肝细胞癌 (COSMIC-312): 一项随机3期研究的最终结果
errLANCET GASTROENTEROLOGY & HEPATOLOGY
IF38.6
err2024-04-01
err19
PREAI
errYau, Thomas; Kaseb, Ahmed; Cheng, Ann-Lii; Qin, Shukui; Zhu, Andrew X.; Chan, Stephen L.; Melkadze, Tamar; Sukeepaisarnjaroen, Wattana; Breder, Valery; Verset, Gontran; Gane, Edward; Borbath, Ivan; Rangel, Jose David Gomez; Ryoo, Baek-Yeol; Makharadze, Tamta; Merle, Philippe; Benzaghou, Fawzi; Milwee, Steven; Wang, Zhong; Curran, Dominic; Kelley, Robin Kate; Rimassa, Lorenza
err分享
err收藏
Comprehensive proteogenomic profiling and biomarker analyses in resected extrahepatic cholangiocarcinoma: A prespecified exploratory analysis of the phase 2 STAMP trial
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errJeong, Hyehyun; Oh, Ji-Hye; Ahn, Hee-Sung; Ryoo, Baek-Yeol; Kim, Kyu-pyo; Jeong, Jae Ho; Park, Inkeun; Hong, Seung-Mo; Shin, Jinho; Park, Chae Won; Cho, Yoo Sook; Kim, Kyunggon; Sung, Chang Ohk; Yoo, Changhoon
err分享
err收藏
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trialRegorafenib联合nivolumab治疗不可切除的肝细胞癌: 2期RENOBATE试验
errNATURE MEDICINE
IF50
err2024-02-19
err14
errOAAI
errKim, Hyung-Don; Jung, Seyoung; Lim, Ho Yeong; Ryoo, Baek-Yeol; Ryu, Min-Hee; Chuah, Samuel; Chon, Hong Jae; Kang, Beodeul; Hong, Jung Yong; Lee, Han Chu; Moon, Deok-Bog; Kim, Ki-Hun; Kim, Tae Won; Tai, David; Chew, Valerie; Lee, Jeong Seok; Finn, Richard S.; Koh, June-Young; Yoo, Changhoon
err分享
err收藏
Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors
errSCIENTIFIC REPORTS
IF3.9
err2024-02-19
err11
errOAAI
errKim, Joo Young; Kim, Jisup; Kim, Yong-il; Yang, Dong-Hoon; Yoo, Changhoon; Park, In Ja; Ryoo, Baek-Yeol; Ryu, Jin-Sook; Hong, Seung-Mo
err分享
err收藏
Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
errEJNMMI PHYSICS
IF3.2
err2024-02-05
err2
errOAAI
errHa, Sejin; Kim, Yong-il; Oh, Jungsu S.; Yoo, Changhoon; Ryoo, Baek-Yeol; Ryu, Jin-Sook
err分享
err收藏
Association between treatment-emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT studyREFLECT研究中治疗高血压与来伐替尼治疗肝癌患者生存率的关系
errCANCER
IF5.1
err2024-01-23
err5
errOAAI
errPiscaglia, Fabio; Ikeda, Kenji; Cheng, Ann-Lii; Kudo, Masatoshi; Ikeda, Masafumi; Breder, Valery; Ryoo, Baek-Yeol; Mody, Kalgi; Ren, Min; Ramji, Zahra; Sung, Max W.
err分享
err收藏
Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma一线阿特珠单抗-贝伐单抗与来伐替尼对晚期肝细胞癌患者的器官特异性反应
errHEPATOLOGY INTERNATIONAL
IF6.1
err2024-01-12
err0
errOAAI
errKim, Hyung-Don; Park, Young-Gyu; Kim, Sejin; Kim, Kyu-Pyo; Park, Sook-Ryun; Ryu, Min-Hee; Ryoo, Baek-Yeol; Yoo, Changhoon
err分享
err收藏
Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea
errTARGETED ONCOLOGY
IF4
err2023-12-18
err3
PREAI
errShin, Yeokyeong; Moon, Bo Hyun; Ryoo, Baek-Yeol; Chang, Heung-Moon; Kim, Kyu-pyo; Hong, Yong Sang; Kim, Tae Won; Ryu, Jin-Sook; Kim, Yong-il; Yoo, Changhoon
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
M
Masatoshi Kudo
H 指数: 143 · 论文数: 2.8K
L
Lewis R. Roberts
H 指数: 128 · 论文数: 1.1K
A
Andrew X. Zhu
H 指数: 116 · 论文数: 823
P
Peter Malfertheiner
H 指数: 115 · 论文数: 2.1K
G
George D. Demetri
H 指数: 114 · 论文数: 637
查看更多